Growth Metrics

Insulet (PODD) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.28%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 22.80%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -27.72%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -0.27%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 77.20%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -20.37%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.32%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 131.27%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 131.27%
Dec 31, 2025 51.38%
Sep 30, 2025 34.31%
Jun 30, 2025 112.93%
Mar 31, 2025 71.74%
Dec 31, 2024 28.94%
Sep 30, 2024 52.36%
Jun 30, 2024 60.25%
Mar 31, 2024 54.26%
Dec 31, 2023 12.88%
Sep 30, 2023 26.58%
Jun 30, 2023 54.31%
Mar 31, 2023 5.90%
Dec 31, 2022 34.85%
Sep 30, 2022 31.14%
Jun 30, 2022 -4.12%
Mar 31, 2022 -39.41%
Dec 31, 2021 13.76%
Sep 30, 2021 -37.01%
Jun 30, 2021 26.44%
Mar 31, 2021 -21.67%
Dec 31, 2020 152.48%
Sep 30, 2020 6.79%
Jun 30, 2020 -78.57%
Mar 31, 2020 36.79%
Dec 31, 2019 -101.75%
Sep 30, 2019 61.98%
Jun 30, 2019 193.23%
Mar 31, 2019 23.18%
Dec 31, 2018 49.59%
Sep 30, 2018 146.23%
Jun 30, 2018 -426.65%
Mar 31, 2018 -40.58%
Dec 31, 2017 -59.71%
Sep 30, 2017 103.91%
Jun 30, 2017 51.62%
Mar 31, 2017 -146.46%
Dec 31, 2016 67.75%
Sep 30, 2016 -97.25%
Jun 30, 2016 -30.15%
Mar 31, 2016 -81.99%
Dec 31, 2015 -42.38%
Sep 30, 2015 40.35%
Jun 30, 2015 26.80%
Mar 31, 2015 9.59%
Dec 31, 2014 30.03%
Sep 30, 2014 34.20%
Jun 30, 2014 35.99%
Mar 31, 2014 33.44%
Dec 31, 2013 15.94%
Sep 30, 2013 28.64%